EP0786999A4 - Procede combine de traitement de l'acne - Google Patents
Procede combine de traitement de l'acneInfo
- Publication number
- EP0786999A4 EP0786999A4 EP95936349A EP95936349A EP0786999A4 EP 0786999 A4 EP0786999 A4 EP 0786999A4 EP 95936349 A EP95936349 A EP 95936349A EP 95936349 A EP95936349 A EP 95936349A EP 0786999 A4 EP0786999 A4 EP 0786999A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- combination method
- acne treatment
- acne
- treatment
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32717194A | 1994-10-21 | 1994-10-21 | |
US327171 | 1994-10-21 | ||
PCT/US1995/013305 WO1996012487A1 (fr) | 1994-10-21 | 1995-10-17 | Procede combine de traitement de l'acne |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0786999A1 EP0786999A1 (fr) | 1997-08-06 |
EP0786999A4 true EP0786999A4 (fr) | 1999-01-20 |
Family
ID=23275460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95936349A Withdrawn EP0786999A4 (fr) | 1994-10-21 | 1995-10-17 | Procede combine de traitement de l'acne |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0786999A4 (fr) |
JP (1) | JPH10508586A (fr) |
AU (1) | AU694576B2 (fr) |
CA (1) | CA2199979A1 (fr) |
WO (1) | WO1996012487A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4526247B2 (ja) * | 2002-07-08 | 2010-08-18 | 第一三共株式会社 | 経口用セファロスポリン製剤 |
US20050136015A1 (en) * | 2003-12-17 | 2005-06-23 | McKie Derrick B. | Topical use of halosalicylic acid derivatives |
WO2008143761A1 (fr) * | 2007-05-14 | 2008-11-27 | Sytheon Ltd. | Compositions d'écran solaire et procédés |
CN107074716A (zh) * | 2014-07-18 | 2017-08-18 | 比奥考金特有限责任公司 | 包含水杨酸酯和聚水杨酸酯的组合物及方法 |
US9918998B2 (en) | 2015-03-23 | 2018-03-20 | BioPharmX, Inc. | Pharmaceutical tetracycline composition for dermatological use |
IT201700060645A1 (it) * | 2017-06-01 | 2018-12-01 | Abiogen Pharma Spa | Uso di xibornolo come agente attivo nel trattamento dell’acne volgare |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992007586A1 (fr) * | 1990-10-31 | 1992-05-14 | Beecham Group Plc | Composition topique comprenant un stimulateur de penetration retinoide |
WO1994020104A1 (fr) * | 1993-03-12 | 1994-09-15 | Merck & Co, Inc. | 4-azasteroides a substitution en position 15 |
WO1995011254A1 (fr) * | 1993-10-21 | 1995-04-27 | Merck & Co., Inc. | INHIBITEURS DE L'ISOZYME 5α-REDUCTASE 1 DE 4-AZA-ANDROSTANE-5 A SUBSTITUTION EN POSITION 16 |
WO1995013077A1 (fr) * | 1993-11-12 | 1995-05-18 | Merck & Co., Inc. | 7β-SUBSTITUES-4-AZA-5α-CHOLESTAN-3-ONES UTILISES COMME INHIBITEURS SELECTIFS DE LA 5α-REDUCTASE 1 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678663A (en) * | 1984-02-06 | 1987-07-07 | Nuetrogena Corporation | Hydroquinone composition having enhanced bio-availability and percutaneous adsorption |
AU4251993A (en) * | 1992-05-20 | 1993-12-13 | Merck & Co., Inc. | Substituted 4-aza-5A-androstan-ones as 5A-reductase inhibitors |
-
1995
- 1995-10-17 CA CA002199979A patent/CA2199979A1/fr not_active Abandoned
- 1995-10-17 WO PCT/US1995/013305 patent/WO1996012487A1/fr not_active Application Discontinuation
- 1995-10-17 AU AU38336/95A patent/AU694576B2/en not_active Ceased
- 1995-10-17 JP JP8514031A patent/JPH10508586A/ja active Pending
- 1995-10-17 EP EP95936349A patent/EP0786999A4/fr not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992007586A1 (fr) * | 1990-10-31 | 1992-05-14 | Beecham Group Plc | Composition topique comprenant un stimulateur de penetration retinoide |
WO1994020104A1 (fr) * | 1993-03-12 | 1994-09-15 | Merck & Co, Inc. | 4-azasteroides a substitution en position 15 |
WO1995011254A1 (fr) * | 1993-10-21 | 1995-04-27 | Merck & Co., Inc. | INHIBITEURS DE L'ISOZYME 5α-REDUCTASE 1 DE 4-AZA-ANDROSTANE-5 A SUBSTITUTION EN POSITION 16 |
WO1995013077A1 (fr) * | 1993-11-12 | 1995-05-18 | Merck & Co., Inc. | 7β-SUBSTITUES-4-AZA-5α-CHOLESTAN-3-ONES UTILISES COMME INHIBITEURS SELECTIFS DE LA 5α-REDUCTASE 1 |
Non-Patent Citations (6)
Title |
---|
"Pschyrembel Klinisches Wörterbuch", 1990, WALTER DE GRUYTER, BERLIN NEW YORK, XP002081095 * |
"Rote Liste", 1991, EDITIO CANTOR, AULENDORF/WÜRTT., XP002065463 * |
"Rote Liste", 1994, EDITIO CANTOR, AULENDORF/WÜRTT., XP002081096 * |
"Rote Liste", 1994, EDITIO CANTOR, AULENDORF/WÜRTT., XP002081097 * |
"The Merck Index, 11th ed.", 1989, MERCK & CO., INC, RAHWAY, N.J. (USA), XP002081094 * |
See also references of WO9612487A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU694576B2 (en) | 1998-07-23 |
CA2199979A1 (fr) | 1996-05-02 |
JPH10508586A (ja) | 1998-08-25 |
AU3833695A (en) | 1996-05-15 |
WO1996012487A1 (fr) | 1996-05-02 |
EP0786999A1 (fr) | 1997-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0792371A4 (fr) | Procede combine de traitement de l'acne | |
IL126203A0 (en) | Method for treating pain | |
EP0906104A4 (fr) | Procede de traitement de la douleur | |
ZA951948B (en) | Apparatus for an efficient photodynamic treatment | |
IL160505A0 (en) | Method and apparatus for acne treatment | |
SG50018A1 (en) | Method for developing treatment | |
AU4017395A (en) | Method for treating anxiety | |
IL126759A0 (en) | Method for treating inflammation | |
GB9605828D0 (en) | Treatment method | |
IL126064A0 (en) | Method for treating pain | |
GB2289946B (en) | Method | |
PL328964A1 (en) | Acne treating method | |
IL124786A0 (en) | Method for treating pain | |
EP0786999A4 (fr) | Procede combine de traitement de l'acne | |
GB9714841D0 (en) | Treatment method | |
AU4017195A (en) | Method for treating anxiety | |
AU3662895A (en) | Method for treating animals | |
KR970006505B1 (en) | Waste treatment method | |
IL119272A0 (en) | Method for treating acne | |
GB9412456D0 (en) | Treatment method | |
GB9417504D0 (en) | Treatment method | |
GB9412134D0 (en) | Treatment method | |
GB9401566D0 (en) | Method | |
GB9614741D0 (en) | Treatment method | |
GB9600610D0 (en) | Treatment method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970521 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19981203 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20001103 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20010314 |